Mutations in CCDC 39 and CCDC 40 are the Major Cause of Primary Ciliary Dyskinesia with Axonemal Disorganization and Absent Inner Dynein Arms by Antony, Dinu et al.
Mutations in CCDC39 and CCDC40 are the major cause of
primary ciliary dyskinesia with axonemal disorganisation and
absent inner dynein arms
Dinu Antony1,a,*, Anita Becker-Heck2,b,*, Maimoona A Zariwala3,*, Miriam Schmidts1,
Alexandros Onoufriadis1, Mitra Forouhan1, Robert Wilson4, Theresa Taylor-Cox5, Ann
Dewar5, Claire Jackson6, Patricia Goggin6, Niki T Loges2, Heike Olbrich2, Martine Jaspers7,
Mark Jorissen7, Margaret W Leigh8, Whitney E Wolf9, M. Leigh Anne Daniels9, Peader G
Noone9, Thomas W Ferkol10, Scott D Sagel11, Margaret Rosenfeld12, Andrew Rutman13,
Abhijit Dixit14, Christopher O’Callaghan13, Jane S Lucas6, Claire Hogg5, Peter J Scambler1,
Richard D Emes15, UK10K16, Eddie MK Chung17, Amelia Shoemark5, Michael R Knowles9,§,
Heymut Omran2,§, and Hannah M Mitchison1,§
1Molecular Medicine Unit and Birth Defects Research Centre, University College London (UCL)
Institute of Child Health, London, UK
2Department of Pediatrics and Adolescent Medicine, University Hospital Muenster, Muenster,
Germany
3Department of Pathology and Laboratory Medicine, UNC School of Medicine, Chapel Hill, NC,
USA
4Respiratory Medicine, Royal Brompton and Harefield NHS Trust, London, UK
5Department of Paediatric Respiratory Medicine and Electron Microscopy Unit, Royal Brompton
and Harefield NHS Trust, London, UK
6Primary Ciliary Dyskinesia Group, University of Southampton Faculty of Medicine, Southampton
NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK
7University Hospitals Leuven, Department of Otorhinolaryngology, Herestraat 49 bus721, 3000
Leuven, Belgium
8Department of Pediatrics, UNC School of Medicine, Chapel Hill, NC, USA
9Department of Medicine, UNC School of Medicine, Chapel Hill, NC, USA
10Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA
11Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA
Correspondence to: Hannah M. Mitchison, Molecular Genetics Unit and Birth Defects Research Centre, University College London
(UCL) Institute of Child Health, 30 Guilford Street, London WC1N 1EH, h.mitchison@ucl.ac.uk, Tel. +44 20 7905 2866, Fax. +44 20
404 6191. Heymut Omran, Department of Pediatrics and Adolescent Medicine, University Hospital Muenster, Muenster, Germany,
heymut.omran@ukmuenster.de, Tel. +49 (251) 83 477 32, Fax. +49 (251) 83 477 35. Michael R. Knowles, Department of Medicine,
UNC School of Medicine, Chapel Hill, NC, USA, knowles@med.unc.edu, Tel. +1 919 966-6780.
16uk10k.org.uk
aCurrent affiliation: Dasman Genome Center Unit, P.O.Box 1180, Dasman 15462, Kuwait
bCurrent affiliation: Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Forum 1, Novartis
Campus Basel, CH-4056, Basel, Switzerland
§Equal contribution.
*These authors contributed equally to the work.
The authors have no conflicts of interest to declare.
Supporting Information for this preprint is available from the Human Mutation editorial office upon request (humu@wiley.com)
NIH Public Access
Author Manuscript
Hum Mutat. Author manuscript; available in PMC 2014 March 01.
Published in final edited form as:













12Children’s Hospital and Regional Medical Center, Seattle, WA, USA
13Department of Infection, Immunity and Inflammation, University of Leicester, Leicester Royal
Infirmary, Leicester, UK
14Department of Clinical Genetics, Nottingham City Hospital, Nottingham, UK
15School of Veterinary Medicine and Science, University of Nottingham, Leicestershire, UK
17General and Adolescent Paediatric Unit, University College London (UCL) Institute of Child
Health, 30 Guilford Street, London WC1N 1EH, UK
Abstract
Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder caused by cilia and
sperm dysmotility. About 12% of cases show perturbed 9+2 microtubule cilia structure and inner
dynein arm (IDA) loss, historically termed ‘radial spoke defect’. We sequenced CCDC39 and
CCDC40 in 54 ‘radial spoke defect’ families, as these are the two genes identified so far to cause
this defect. We discovered biallelic mutations in a remarkable 69% (37/54) of families, including
identification of 25 (19 novel) mutant alleles (12 in CCDC39 and 13 in CCDC40). All the
mutations were nonsense, splice and frameshift predicting early protein truncation, which suggests
this defect is caused by ‘null’ alleles conferring complete protein loss. Most families (73%; 27/37)
had homozygous mutations, including families from outbred populations. A major putative
hotspot mutation was identified, CCDC40 c.248delC, as well as several other possible hotspot
mutations. Together, these findings highlight the key role of CCDC39 and CCDC40 in PCD with
axonemal disorganisation and IDA loss, and these genes represent major candidates for genetic
testing in families affected by this ciliary phenotype. We show that radial spoke structures are
largely intact in these patients and propose this ciliary ultrastructural abnormality be referred to as
‘IDA and nexin-dynein regulatory complex (N-DRC) defect’, rather than ‘radial spoke defect’.
Keywords
primary ciliary dyskinesia; cilia; CCDC39; CCDC40; radial spoke; dynein regulatory complex;
nexin link
Introduction
Primary ciliary dyskinesia (PCD) is a recessively inherited disorder which arises from cilia/
sperm dysmotility that is associated with a number of different axonemal ultrastructural
abnormalities. The symptoms of deficient mucociliary clearance are usually obvious from
birth, and patients have recurrent respiratory tract infections leading to irreversible lung
damage (bronchiectasis). They also manifest with otitis media, chronic sinusitis, and
subfertility. Internal organ laterality is randomised with about half of patients having situs
inversus, an association reflecting dysmotility of nodal cilia during embryonic development.
Motile flagella and cilia are related organelles found on the surface of cells evolutionarily
conserved across 1.6 billion years from the flagella of the green alga Chlamydomonas to the
ciliated respiratory and embryonic node cells of vertebrates (Pazour, 2004). In humans,
motile cilia have a common microtubule-based ultrastructure (axoneme), comprising 9
peripheral microtubule doublets either surrounding (in ‘9+2’ motile respiratory and fallopian
tube cilia, and sperm flagella) or lacking (in ‘9+0’ motile nodal cilia) a central microtubule
pair (Becker-Heck et al., 2012; Fliegauf et al., 2007), and linked to a variety of microtubule-
associated proteins. These include the inner and outer dynein arm motor complexes, which
project from the peripheral microtubule doublets; the radial spokes, which provide a radial
scaffold between the central pair and peripheral microtubules and facilitate signal
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transduction from the centre out to the dynein arms to govern ciliary beat and waveform
(Becker-Heck et al., 2012); and nexin-dynein regulatory complexes (N-DRC), which attach
between adjacent peripheral doublets to facilitate inner dynein arm attachment and regulate
dynein activity (Heuser et al., 2009). This complex superstructure creates the rigid
organisation along the entire length of the axoneme which is required for motor ATPase
signalling to generate a uniquely coordinated and self-propagating beat (Mitchison and
Mitchison, 2010).
PCD is genetically heterogeneous with 18 identified genes causing non-syndromic disease.
The range of genetic defects cause a small number of defective ciliary ultrastructural
subtypes by current imaging resolution, and no correlations have been defined between
ultrastructural defects and the course of disease (Kispert et al., 2003). Mutations in genes
that cause axonemal outer dynein arm (ODA) defects (DNAH5, DNAI1, DNAI2, DNAL1,
TXNDC3 and CCDC114) are the genetic basis of the majority of PCD cases (Olbrich et al.,
2002; Pennarun et al., 1999; Loges et al., 2008; Mazor et al., 2011; Duriez et al., 2007;
Bartoloni et al., 2002; Onoufriadis et al., 2012; Knowles et al., 2012a). Mutations in genes
encoding components of the radial spoke head (RSPH4A and RSPH9) cause defects
involving the central pair microtubules (Castleman et al., 2009). Mutations in genes
encoding cytoplasmic or dual location proteins involved in the assembly and transport of
dynein arm components into the axoneme from the cell body (DNAAF1/LRRC50,
DNAAF2/KTU, DNAAF3/PF22, CCDC103, HEATR2 and LRRC6) cause inner and outer
dynein arm defects (Loges et al., 2009; Duquesnoy et al., 2009; Omran et al., 2008;
Mitchison et al., 2012; Panizzi et al., 2012; Horani et al., 2012; Kott et al., 2012). Lastly,
two genes associated with PCD give rise to no discernible ultrastructural defects of the
axoneme (DNAH11) or defects of the central microtubule pair C2b projection that are too
subtle to be easily detected (HYDIN) (Bartoloni et al., 2002; Knowles et al., 2012b; Olbrich
et al., 2012).
Mutations in two genes, CCDC39 (MIM# 613798) (Merveille et al., 2011) and CCDC40
(MIM# 613799) (Becker-Heck et al., 2011), have recently been shown in PCD patients that
have a defect of the cilia axoneme, involving loss of the inner dynein arms accompanied by
a variably expressed disorganisation of the 9+2 microtubule arrangement. Recent
transmission electron microscopy (TEM) surveys of several different PCD cohorts estimated
that at least ~12% of all PCD cases have this defect (Chilvers et al., 2003; Shoemark et al.,
2012; Papon et al., 2010). The nine peripheral microtubules are retained but are
mislocalised, often becoming more centralised, while the central microtubule pair may be
variously lost (9+0), eccentrically positioned towards the periphery (9+2), or increased in
number with a supernumerary central pair present (9+4); and the inner dynein arm structures
are reduced or absent. Furthermore, in axonemes with this defect abnormal and/or absent N-
DRC complexes have been recorded (Schneeberger et al., 1980; Konradova et al., 1982) and
radial spokes (Sturgess et al., 1979; Antonelli et al., 1981). This ultrastructural defect has
historically often been referred to as ‘radial spoke defect’. The reasons for the various
disarrangements are unclear, but since a range of microtubule disorganisations may be seen
within a single TEM sample of respiratory epithelia from a patient, it is even possible that a
variety of changes may occur along the length of the axoneme. These perturbations of
structure create a characteristic ciliary motility defect with a beating pattern of mixed
appearance, where stiff cilia displaying a reduced amplitude (70%) and cilia that are fully
immotile (30%) are both visible (Chilvers et al., 2003; Merveille et al., 2011; Becker-Heck
et al., 2011). The partially retained motility may be explained by activity of the outer dynein
arm motors, but cilia waveform is misregulated and the mean ciliary beat frequency is
reduced (Chilvers et al., 2003).
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The CCDC39 and CCDC40 genes encode structurally related coiled-coil domain-containing
proteins of unknown function that are localised to the axoneme (Merveille et al., 2011;
Becker-Heck et al., 2011; Becker-Heck et al., 2012). The loss of IDAs and N-DRCs from
ciliary axonemes of CCDC39 and CCDC40 patients has been previously confirmed using
antibodies to DNALI1 and the N-DRC component GAS11/8 respectively (Merveille et al.,
2011; Becker-Heck et al., 2011), and it is proposed that CCDC39 and CCDC40 proteins
interact with N-DRC components and play a role in inner dynein arm attachment. Neither
protein has yet been identified in proteomic studies of N-DRC composition (Lin 2011); thus,
rather than being integral N-DRC proteins, they may be otherwise involved in N-DRC
assembly, microtubule attachment, or protein interactions. The role of the CCDC39 and
CCDC40 proteins in the structure and function of radial spokes is not known, and radial
spokes in cilia from ‘radial spoke defect’ patients have never been examined at the
molecular level using antibody staining techniques.
In this study, we applied a combination of candidate gene Sanger sequencing and next-
generation whole exome sequencing to identify the genetic cause of PCD in a large cohort of
‘radial spoke defect’ patients with cilia dysmotility associated with axonemal microtubule
disorganisation and absence of IDAs. We also used antibody and immunofluorescence




A total of 54 unrelated PCD families were involved in the screen. Parallel mutational
analysis on a collection of 17 families from UCL-ICH (labelled in the text by ‘PCD’ prefix),
4 from Belgium/UHM (University Hospital Muenster) (‘OP’ and ‘KUL’ prefix) and 33 from
UNC (‘UNC’ prefix) was performed using genomic DNA samples obtained from peripheral
blood cells. All families agreed under informed consent to participate in this study in
accordance with protocols approved by the ethical committees of the Institute of Child
Health/Great Ormond Street Hospital and University College London Hospital NHS Trust,
and those of collaborating institutions.
CCDC39 and CCDC40 mutation identification
The transcripts referred to are CCDC39 NM_181426.1 and CCDC40 NM_017950.2. Sanger
sequencing was performed by amplifying and sequencing the coding exons and flanking
intronic sequences of CCDC39 and CCDC40 (primer sequence available on request).
Sequence alignments for variant identification were made using Sequencher software (Gene
Codes Corporation). Whole exome sequencing was performed for most samples by
capturing the exons using the Agilent SureSelect All Exon Human V3 (50 Mb) kit. TruSeq
Pair End Cluster kit V3 was used for cluster generation and 100 bp. paired-end reads were
generated on an Illumina HiSeq 2000 analyser using Illumina TruSeq V3 SBS sequencing
chemistry. The BWA alignment tool (Li and Durbin, 2010) was used to map sequence reads
back to the genome (human reference hg19) then the GATK tool suite (McKenna et al.,
2010) was used to process the alignments and identify variations. The SNP-Effects (http://
snpeff.sourceforge.net/) and ANNOVAR (Wang et al., 2010) programs were used to
annotate variations. The details of the whole exome sequencing are presented in Supp. Table
S1.
In one case (PCD22) exome sequencing was performed as part of the Wellcome Trust
Sanger Institute UK10K Project as described previously (Olbrich et al., 2012; Onoufriadis et
al., 2012). Exome variant analysis was achieved by filtering of the total variant list
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according to consistent autosomal recessive inheritance pattern, novelty in comparison to
human polymorphism databases including the 1000 Genomes (1000 Genomes Project
Consortium, 2010) and NHLBI Exome Sequencing projects (http://evs.gs.washington.edu/
EVS) and dbSNP v135, and finally for their functional significance. This analysis required
the presence of at least one homozygous or two heterozygous changes occurring with an
estimated frequency <0.01, and all the patients included in this study had clear-cut biallelic
variants in the CCDC39 and CCDC40 genes that were identified via excellent coverage in
all cases, without any other obvious causal candidates indicated. Sanger sequencing was
used to confirm all the identified variants from exome sequencing and to verify the
segregation pattern of each change in other unaffected family members, identified by both
methods.
Nucleotide numbering reflects cDNA numbering with +1 corresponding to the A of the
ATG translation initiation codon in the reference sequence, according to journal guidelines
(www.hgvs.org/mutnomen). The initiation codon is codon 1.
Electron microscopy and high-speed video light microscopy
Respiratory epithelial cells were obtained using a cytology brush or rhinoprobe from the
inferior turbinate of participants and immediately analysed for cilia beat frequency and beat
pattern under light microscopy as described (Chilvers et al., 2003). Samples were fixed in
glutaraldehyde and an ultrastructural defect of the cilia was confirmed by electron
microscopy (Rutland et al., 1982).
Immunofluorescence analysis
The effect of the CCDC40 splice mutation in patient 114 II:1 was confirmed by
Immunofluorescence analysis. Respiratory epithelial cells obtained by nasal brush biopsy
were suspended in cell culture medium. Samples were spread onto glass slides, air dried and
stored at −80°C until use. Cells were fixed with 4% PFA for 4 minutes at room temperature,
washed 5X with PBS and then permeabilized with 0.5% TritonX100 for 10 minutes. After 5
more washes with PBS cells were incubated with 5% bovine serum albumin (Sigma) in PBS
for 1 hour. The cells were then incubated with primary antibodies overnight at room
temperature using the following dilutions: CCDC39 antibody 1:100 (rabbit polyclonal
Sigma); RSPH4A 1:100 (rabbit polyclonal Sigma); ROPN1L 1:200 (rabbit polyclonal
Sigma) monoclonal mouse anti-acetylated and gamma tubulin 1:500 (Sigma) over night at
room temperature. After 5 washes with PBS cells were incubated with secondary anti-rabbit
antibody (Alexa Fluor 488 Molecular Probes Invitrogen) and secondary anti-mouse antibody
(Alexa Fluor 594 Molecular Probes Invitrogen). DNA was stained using DAPI (Invitrogen).
Cells were finally washed 5X with PBS, mounted in Vectashield (Vector Laboratories) and
confocal images were taken using a Zeiss LSM 710.
Protein modelling
Conserved domains were predicted using SMART (Letunic et al., 2012) and CDD
(Marchler-Bauer et al., 2011), and coiled-coil protein folds predicted using Paircoil2
(McDonnell et al., 2006) with minimum window size of 28 amino acids. Protein homologies
and network predictions were identified using PSI-BLAST (Altschul et al., 1997) to search
the nr database and STRING 9.0 (Szklarczyk et al., 2011).
Results
The entire coding region and flanking intronic sequences of the CCDC39 and CCDC40
genes were sequenced in a cohort of 59 patients from 54 PCD families that displayed ciliary
dysmotility and a similar axonemal ultrastructural phenotype to that associated with
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CCDC39 and CCDC40 mutations (Merveille et al., 2011; Becker-Heck et al., 2011). The
patients were all diagnosed based on having a classic PCD phenotype, including recurrent
respiratory tract infections, pneumonia, rhinosinusitis, otitis media usually requiring
repeated grommet insertion, and age-dependent bronchiectasis, where chest CT data was
available. Most patients showed symptoms in the neonatal period, with respiratory distress,
as well as recurrent airway infections. In addition, patients showed abnormal cilia
ultrastructure and motility at the electron and light microscopic levels respectively, as
described below.
Combined whole exome sequencing and Sanger sequencing analysis in the 54 families
identified a total of 25 different putative mutations, 12 in CCDC39 and 13 in CCDC40 that
affected a total of 47 patients in 37 families (Table 1). All the changes consisted of
frameshift, nonsense and essential splice site mutations, the latter all affecting the 100%
conserved splicing consensus intronic nucleotides. None of the identified variants are
present in dbSNP (Sherry et al., 2001), or the 1000 Genomes Project (1000 Genomes Project
Consortium, 2010) and NHLBI ESP Exome Variant Server (http://evs.gs.washington.edu/
EVS/) exome repositories, nor where they detected in 180 exomes available via the UK10K
project (uk10k.org). Genotyping of all available members of the affected families carrying
CCDC39/40 mutations showed that all the identified variants segregated correctly in
association with disease status, having an autosomal recessive inheritance pattern. Of the 37
families carrying CCDC39/40 mutations, segregation was possible for 26 families, the other
11 families being represented by single affected patients (Figs. 1A, B and Supp. Fig. S1).
Thus, in this study just 17/54 families did not carry CCDC39 and CCDC40 variants, so these
two genes accounted for 69% (37/54) of families.
The clinical details for the affected families are shown in Supp. Table S2. In all patients with
either CCDC39 or CCDC40 mutations, TEM of respiratory bronchial epithelial cells showed
similar microtubule disorganisation comprising disorganisation of the peripheral
microtubule doublets, absent or shifted central pairs. In all samples there was a documented
reduction or complete loss of the inner dynein arms. Therefore, the CCDC39 and CCDC40
mutations cause defects that are indistinguishable by TEM.
A detailed clinical review was performed for six CCDC39 and three CCDC40 patients under
the care of the Royal Brompton Hospital London that were part of the UCL-ICH cohort,
then compared to findings on the UNC cohort of 20 patients. Their nasal nitric oxide levels
were low in both cohorts at 45-79 ppb and 6-34 nl/min respectively, as expected for PCD
patients where the normal mean level is 639 ppb (range 422-890) (Shoemark and Wilson,
2009). TEM of at least 30 cilia cross sections was examined in UCL-ICH patients which
revealed disarrangement of the outer microtubular doublets in 43% (CCDC39) and 36%
(CCDC40) of cilia cross sections, mainly involving translocation of peripheral microtubular
doublets and acentric microtubular central pairs (Fig. 1Cb–d). Other less prominent features
included additional central microtubules or absence of the central pair structures (Fig. 1Cc–
e). Inner dynein arms were absent from 69% (CCDC39) and 90% (CCDC40) of cilia cross
sections (Fig 1Cb–e). The outer dynein arm was apparent throughout. In one subject with
CCDC40 mutations a fallopian tube biopsy revealed similar abnormalities (Fig. 1Ce). The
UNC study found similar results in TEM of at least 30 cilia cross-sections from CCDC39/40
patients, with 26% of cilia on average showing microtubule disorganisation and 92%
showing IDAs lost on average, and outer dynein arms present in all. High speed video
analysis of ciliated nasal brush biopsies of UCL-ICH patients with CCDC39 mutations
showed the majority of cilia to be static at 37°C (~ 75%), and also at 25°C in UNC
CCDC39/40 patients. In patches where movement was present, the CCDC39 mutant cilia
beat pattern was typically stiff, rigid and ineffective (Supp. Movie. S1, S2). This was
indistinguishable from CCDC40 (Supp. Movie S3). A control sample is shown in Supp.
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Movie S4. In cilia which demonstrated motility there were a wide range of ciliary beat
frequencies (range 3.3-13.0 Hz). Mean 37°C CBF was 8.1Hz in CCDC39 patients and 9.2Hz
in CCDC40 patients, where the normal range is 11-16 Hz. In UNC CCDC39/40 patients the
mean 25°C CBF was reduced to 4.3Hz from the normal mean value of 7.3Hz. In three
CCDC39 and one CCDC40 patients, sperm dysmotility was also recorded (data not shown).
We used a number of protein modelling tools to identify the location of CCDC39 and
CCDC40 mutations identified in this study, and those previously published, in relation to
putative protein functional domains. CCDC39 has 941 residues and 10 predicted coiled-
coils, in agreement with previous structural modelling (Merveille et al., 2011), and CCDC40
has 1142 residues and 8 predicted coiled-coils (Fig. 2A, B). Both proteins contain two large
Structural Maintenance of Chromosomes (SMC) conserved domains which, as previously
discussed, are found in several ciliary proteins and likely play a role in microtubule-based
ciliary transport processes (Merveille et al., 2011). A conserved BRE1 domain (Kim et al.,
2005) was identified in CCDC40, but the significance is not clear. STRING predicted
interactions between CCDC39 and protein phosphatase 1 F-actin cytoskeleton targeting
subunit (phostensin), an actin filament-binding protein that can modulate actin dynamics
that has not been connected with cilia functions (Lai et al., 2009); and between CCDC40 and
MCTP1, a membrane protein with putative calcium mediated signalling functions (Shin et
al., 2005).
Of the 25 mutations reported here, 19 are novel to this study. Fig. 2 shows the location of the
identified mutations in both genes and encoded CCDC39 and CCDC40 proteins. All the
identified mutations predict premature protein truncation via nonsense (5/12 and 5/13 for
CCDC39 and CCDC40 respectively) and frameshift effects, the latter either arising from
small indels within the coding sequence (5/12 and 6/13 respectively), or from single base
substitutions of the essential splice site residues at the immediate exon-intron boundaries
(2/12 and 2/13, respectively). All these variants are likely to give rise to null alleles via
nonsense-mediated decay, indicating that the inner dynein arm and microtubule
disorganisation phenotype arises from complete loss of these proteins and consequent loss-
of-function. This supports the published evidence that mutations in CCDC39 and CCDC40
have a similar functional effect in being highly deleterious (Merveille et al., 2011; Becker-
Heck et al., 2011). No particular clustering of mutations is evident since in both proteins the
changes that we have identified, and previously published mutations, are evenly distributed
across the gene and protein structure. This suggests that protein termination at any point
leads to the same deleterious dysfunction.
This study identified six mutations that have already been reported: a CCDC39 splice site
mutation c.357+1G>C (Merveille et al., 2011) and the CCDC40 frameshift mutations c.
248delC and c.3129delC; and nonsense mutations c.2440C>T, c.961C>T and c.1345C>T
(Becker-Heck et al., 2011; Nakhleh et al., 2012). All of these mutations are only present in
patients from families of Northern European descent, except for CCDC39 c.357+1G>C
which was reported in 1 Turkish and 3 Northern European families previously. In addition,
two mutations that are novel to this study were shared amongst different families within our
cohort: a CCDC39 frameshift mutation c.526_527delCT was common to both a UK and a
Zimbabwean origin family, and a CCDC40 splice site mutation c.2712-1G>T was shared in
two UK and one US families.
We found that the CCDC40 frameshift mutation c.248delC is extremely common, and is
restricted to families of N. European origin spread worldwide, suggesting an ancient shared
ancestry and past Founder effect mutation occurrence. c.248delC accounts for 34/56
N.European ancestry disease chromosomes in CCDC40 disease, a remarkable 63% (Table
1). It is not known whether the other smaller putative ‘hotspot’ mutations may also represent
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Caucasian N. European-origin Founder effect mutations, or whether they are functionally
significant changes that have occurred separately many times in different countries. Despite
the fact that only five out of the total 37 CCDC39/40 families carrying mutations were
consanguineous, there was an overall predominance of homozygous changes amongst the
families, with 27/37 (73%) of CCDC39/40 families carrying homozygous changes due to
identical alleles being inherited from both parents. The Turkish-origin in one family for
CCDC39 c.357+1G>C (Merveille et al., 2011) and Zimbabwean origin in one family for
CCDC39 c.526_527delCT indicates a more complex evolution of these common mutations
than a N. European Founder effect, and the possibility of Non-Founder mutation hotspots.
However, firm conclusions are precluded by the small family numbers. It should be noted
that although the family UCL210 carrying a homozygous nonsense mutation in CCDC40, c.
2245G>T, was not aware of familial consanguinity, they orginate from a small Punjabi-
speaking isolate located in Afghanistan likely to have underlying ancestral endogamy and
consanguinity.
The ciliary ultrastructure of patients with CCDC39 and CCDC40 mutations has been
referred to as ‘radial spoke defect’, and several reports have suggested that radial spokes are
defective (Sturgess et al., 1979; Antonelli et al., 1981; Merveille et al., 2011; Becker-Heck
et al., 2011). We sought to investigate radial spoke structures in the patients at the molecular
level, by high-resolution immunofluorescence analysis of nasal epithelial cells. In one
CCDC40 mutation patient 114 II:1, we confirmed an absence of the CCDC39 protein along
the length of the axoneme in all cilia analysed in this patient (Figs. 3A, B). These findings
are consistent with published information reporting the loss of CCDC39 from axonemes of
CCDC40 mutant cilia. However, both RSPH4A which is a radial spoke ‘head’ component
(Yang et al., 2006) and ROPN1L/RSP11 which is a radial spoke ‘stalk’ component (Yang et
al., 2006; O’Toole et al., 2012) were present in axonemes from the patient as well as
controls, with no differences in protein levels observable (Figs. 3C, D and Supp. Fig. S2).
This shows for the first time that components of the radial spoke structures are present in
axonemes of patients that have long been typically referred to as ‘radial spoke defect’. These
data do not however prove that these radial spoke proteins are properly localized in the cilia
superstructure, thus they may be present but not functioning correctly.
Discussion
This study shows that CCDC39 and CCDC40 mutations are the major cause of PCD in
patients with the previously termed ‘radial spoke defect’, which is characterised by a ciliary
axonemal loss of inner dynein arms and axonemal disorganisation. We report the
identification of 25 different allelic mutations in CCDC39 and CCDC40 affecting a total of
46 PCD patients in 37 families. Nineteen of the mutations are novel to this study, while six
are shared with patients in three previously published reports (Merveille et al., 2011;
Becker-Heck et al., 2011; Nakhleh et al., 2012). A report of additional mutations not
referred to here was also published during preparation of this manuscript (Blanchon et al.,
2012). In our cohort, two of the novel mutations are found in more than one family across
different population origins. Therefore in our patients and also in those reported elsewhere,
there are putative common or ‘hotspot’ mutations for both genes; specifically c.357+1G>C
and c.526_527delCT in CCDC39, and c.248delC, c.3129delC, c.2440C>T, c.961C>T, c.
1345C>T and c.2712-1G>T in CCDC40. The c.248delC mutation is very common, affecting
18/28 CCDC40 families (64%) in this study, in particular US-origin families. The total
number of different alleles in CCDC39/40 is smaller than might be expected from the
outbred populations we have analysed. This collective evidence is rather unusual for PCD
disease and supports the idea that critical regions or important functional residues within the
two proteins may be repeatedly vulnerable to mutation arising separately within different
populations, probably combined with some localised Founder effects.
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Mutations in either gene give rise to the same ciliary and clinical phenotypes, and ciliary
defects that are indistinguishable using current methodologies of TEM and high-speed video
microscopy. Our TEM and cilia dysmotility findings are consistent with published findings
for CCDC39 and CCDC40 mutation (Merveille et al., 2011; Becker-Heck et al., 2011).
Therefore, mutations in these genes give rise to analogous defects, which is consistent with
similarities in their protein architecture, axonemal localisation, and putative biological
role(s). The large number of patients within the ‘radial spoke defect’ subtype of PCD that
carry mutations in CCDC39/40 is striking given the extensive underlying genetic
heterogeneity in PCD.
Notably, all CCDC39/40 mutations give rise to null alleles, due to nonsense, frameshift or
conserved splice site effects. This suggests that complete loss of protein is required to give
the characteristic ultrastructural defects, and individuals carrying ‘milder’ effect alleles
would likely not express a PCD-like disease phenotype, although this might affect disease
severity of other airway diseases. This is in direct contrast with other ciliopathy disorders
(affecting non-motile primary cilia) where missense mutations predominantly confer
disease, and it is reported that two null alleles are never seen in patients because they affect
development so severely that they are incompatible with embryonic survival (Dagoneau et
al., 2009; Beales et al., 2007; Davis et al., 2011; Schmidts et al., 2012). An intriguing
alternative hypothesis is that CCDC39/CCDC40 missense mutations are not observed
because they may be more deleterious than loss of function mutations, rather than less
deleterious, and are thus selected against in the surviving clinical patient population. This
model is also plausible, for example, if CCDC39/CCDC40 were to orchestrate cilia
assembly in multiprotein complexes, such that loss of function mutations could be better
tolerated than gain-of-function missense mutations.
Combining our data with that of the three previous reports, a total of 26 mutations in
CCDC39 and 21 mutations in CCDC40 have been identified, all encoding predicted null
alleles. In N-DRC Chlamydomonas null-mutant strains, loss of any one of the N-DRC
components gives rise to complete loss of the entire N-DRC structure (Piperno et al., 1994).
CCDC39 and CCDC40 mutation patients also lack at least some of the N-DRC structure,
and this also appears to be associated with mutations causing complete loss of protein.
The predicted loss-of-function reported for all CCDC39 and CCDC40 mutations correlates
with the widespread distribution of mutations across both genes, without any evidence of
clustering. We expect that all mutations identified in these two genes would make the
protein subject to nonsense mediated decay; however, both proteins contain multiple
functionally important domains that are highly evolutionarily conserved across species and
likely critical to function. The possible role of the BRE1 domain in CCDC40 is less clear,
but the large SMC domains in both proteins are thought to be involved in microtubule
transporting (Merveille et al., 2011). Both proteins have multiple coiled-coil domains, which
leads to a compositional bias of charged and hydrophobic residues containing many lysine,
leucine and glutamic acid residues which are generally located at the ‘surface’ of the coiled-
coil domains involved in conferring solubility and interaction properties. The 10 nonsense
mutations identified in this study mostly affect glutamic acid or arginine residues, mostly in
coiled-coil domains; however, their codon composition makes these residues prone to
nonsense mutations, rather than indicating specific functional importance at those residues.
Coiled-coil domains are found in many different proteins with diverse functions (Strauss and
Keller, 2008), including structural and motor proteins. They are also associated with signal
transduction functions, and assembly/disassembly of protein complexes, which may relate to
the inner dynein arm-N-DRC-radial spoke complexes of cilia. If the stability provided by
multiple coiled-coils is mutated, this may result in reduced efficiency or loss of protein
function. Alternatively, some motor proteins have intrinsic instability in the coiled-coil
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domains to allow the relaxing of tertiary structure and movement of the motor proteins,
which could be important in the cilia.
In contrast with N-DRC components, components of the radial spokes, such as the spoke
‘head’ protein RSPH4A and spoke ‘stalk’ protein ROPN1L, are present in CCDC40 mutant
axonemes. This provides the first evidence that the ultrastructural defect in patients with
CCDC39 /CCDC40 mutations, commonly referred to as ‘radial spoke defect’, may not
reflect a loss of spokes, but proves supporting evidence that they may remain largely intact.
We have not been able to exclude the possibility that radial spoke components may be
present, but mislocalised, misattached, incomplete or non-functional for other reasons.
However, we can conclude that this defect may be more accurately referred to as ‘IDA and
N-DRC defect’, rather than ‘radial spoke defect’.
It is not yet clear how this ciliary ultrastructural defect arises, because little is known about
the formation and co-assembly of the human inner dynein arms, radial spokes and N-DRC
structures, which are all attached in close proximity at the peripheral doublets. These
components are all positioned at regular periodicity along the entire axoneme length, and
form a sophisticated regulatory network governing dynein activity that is key to cilia
motility. The loss of IDAs and N-DRC complexes together in CCDC39 and CCDC40
mutant axonemes is consistent with the role that the N-DRC plays in tethering of IDA
components, as shown in Chlamydomonas. The resultant disorganisation of the peripheral
microtubules and the resultant instability of the central pair apparatus, indicates that these
structures are critical for integrity and motility of the axoneme. Studies of Chlamydomonas
motility mutant strains suggest the N-DRC has a number of roles apart from binding of the
inner dynein arms to the peripheral microtubules, which includes mediating signalling from
the central pair-radial spoke complex to the dynein arms, and influencing dynein-controlled
axonemal bending (Piperno et al., 1994; Lin et al., 2011; Lin et al., 2011). Thus, a deficiency
in these regulatory mechanisms could also explain the defect. In contrast, even though the
radial spokes are located close to the IDA-N-DRC components of axonemes, they may not
be directly involved in the dysmotility in CCDC39 and CCDC40 mutation patients, but are
bystanders that are perturbed secondarily to microtubule disorganisation.
The IDA-N-DRC defect accounts for at least 12% of PCD cases, and the great majority of
these are caused by mutations in CCDC39 and CCDC40 (69% in this study). Mutations in
these genes may have an specially increased prevalence within the isolated and
consanguineous Afghanistan-Punjabi and UK-based Pakistani populations. The high
prevalence of these two genes, together, as causative for this subtype of PCD, makes these
results significant for clinical application, including the development of prenatal and carrier
genetic tests in at-risk families, and for development of genetic therapeutic strategies.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Mutation segregation and ultrastructural defects in selected CCDC39 and CCDC40 patients.
A, B: PCD family pedigrees from the UCL-ICH cohort with autosomal recessive inheritance
of CCDC39 and CCDC40 mutations. Affected individuals are indicated by black symbols,
consanguineous marriages by a double horizontal line. Segregation patterns for the rest of
the cohort are shown in Supp. Figure S1. C: (a) Normal 9+2 ciliary ultrastructure shown;
ODA, outer dynein arm; IDA, inner dynein arm; N-DRC, nexin-dynein regulatory complex.
Representative transmission electron micrographs of cells from nasal brush biopsy of
CCDC40 patient 114 II:1 show (b) consistent loss of inner dynein arms (lightening strikes),
typical translocation of peripheral outer doublet microtubules (white arrow), accentric
microtubular central pairs (white arrow head). In addition both extra central microtubules (c,
black arrow) and total absence of the central microtubular pair (d, black arrowhead) were
occasionally seen. (d) Similar findings were observed in a fallopian tube biopsy of the same
patient. Scale bar, 200 nm.
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Location of mutations in CCDC39 and CCDC40. A, B: Location of CCDC39 and CCDC40
mutations identified in this study indicated below the gene and protein images in red;
mutations identified in two previous studies indicated above in black ((Merveille et al.,
2011; Becker-Heck et al., 2011; Nakhleh et al., 2012). Several predicted protein domains are
indicated by rectangles: coiled coil domains (green, amino acid numbers shown), Structural
Maintenance of Chromosomes domains (SMC, blue) and domains with similarity to yeast
BRE1 histone ubiquitylation protein (BRE1, purple).
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Localisation of axonemal components in CCDC40 patient respiratory cells. A:
Representative immunofluorescent images of respiratory cells localise CCDC39 protein
(green) along the length of the ciliary axonemes in control cells. B: Complete absence of
CCDC39 from axonemes from a patient 114 II:1 carrying CCDC40 mutations. Dual staining
with anti-acetylated alpha tubulin (axonemes) and anti-gamma tubulin (basal bodies) was
used to stain the cilia (red). C, D: RSPH4A (green) localises along the length of axonemes at
similar levels in cells from both control and patient 114 II:1 carrying CCDC40 mutations.
DNA in nuclei was stained using DAPI. DIC indicates differential interference contrast
microscopy images.
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